IPO Update: Juno has biggest 2014 offering as investors chase CAR-T stocks

Juno Therapeutics had the biggest biotechnology initial public offering of 2014 and its stock closed 45.8% above the IPO price on 19 December, the company's first day of trading, showing how intensely interested investors have become in chimeric antigen receptor T-cell (CAR-T) therapies.